Loading clinical trials...
Loading clinical trials...
The objective of the present study is to identify brain networks in patients that contribute to successfully learning self-regulation with real-time fMRI.
Neurofeedback has been established as a promising non-pharmacological therapeutic approach. However, patients differ in their ability to learn control over their own brain activity with neurofeedback. It is thus crucial to understand the brain networks that mediate learned self-regulation with real-time fMRI. The objective of the present study is thus to identify brain networks in patients that contribute to successfully learning self-regulation with real-time fMRI. To achieve this goal, patients suffering from depression, post-traumatic stress disorder, and nicotine addiction will be trained to improve their self-regulation skills using established real-time fMRI neurofeedback protocols.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Hospital of Psychiatry, University of Zurich
Zurich, Canton of Zurich, Switzerland
Start Date
May 1, 2017
Primary Completion Date
September 30, 2020
Completion Date
September 30, 2020
Last Updated
May 24, 2017
210
ESTIMATED participants
Neurofeedback training
OTHER
Sham Feedback
OTHER
Lead Sponsor
Frank Scharnowski
NCT07360600
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions